Related Experiment Video
Updated: Aug 10, 2026

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
Published on: March 15, 2016
Fibroblast growth factor-2 stimulates endothelial nitric oxide synthase expression and inhibits apoptosis by a nitric
P R Murphy1, M Limoges, F Dodd
1Departments of Physiology and Biophysics, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada B3H 4H7.
Abstract:
We recently reported that the rat Nb2 T lymphoma cells expressed messenger RNAs (mRNAs) encoding both fibroblast growth factor-2 (FGF-2) and the FGF receptor, suggesting possible paracrine and/or autocrine roles for FGF-2 in lymphoma cell function. We have also shown that the Nb2 cells expressed endothelial nitric oxide synthase (eNOS) and produced low levels of nitric oxide (NO) that inhibited apoptosis of PRL-deprived cells via a PRL-independent, bcl-2-mediated pathway. In this study the effects of PRL and FGF-2 on Nb2 cell survival and NO production were further investigated. The percentages of nonapoptotic cells in PRL-treated vs. PRL-deprived cultures after 6 days were 95% and 53%, respectively. Addition of FGF-2 to PRL-deprived Nb2 cells did not stimulate cell proliferation, but the onset of apoptosis was significantly inhibited, such that more than 85% of the cells remained nonapoptotic after 6 days. The steady state levels of bcl-2 and bag-1 mRNAs were low in PRL-deprived Nb2 cells, but were markedly increased by PRL or FGF-2. bcl-2 expression was induced within 1 h of PRL or FGF-2 addition and continued to increase to a level 20- to 25-fold above the control level within 24 h. bag-1 expression also increased within 1 h after the addition of PRL or FGF-2, was maximal within 8 h, and declined slowly thereafter. The levels of eNOS mRNAs were low but detectable in growth-arrested Nb2 cells, and PRL further down-regulated eNOS mRNA levels over the next 24 h. In contrast, FGF-2 significantly increased eNOS mRNA levels within 2 h to reach a peak 10-fold induction by 12 h. FGF-2 stimulation of eNOS mRNA was accompanied by a 2- to 3.5-fold increase in cellular levels of the eNOS protein and a 2.5-fold increase in serine-phosphorylated eNOS. However, the ratio of serine-phosphorylated eNOS vs. total cellular eNOS was unchanged, indicating that FGF-2 did not affect the serine phosphorylation status of eNOS. Nb2 cells produced low basal levels of NO, which increased with increasing L-arginine concentrations. PRL did not further increase NO release in the presence of L-arginine (0.1 or 1 mM), but FGF-2 significantly (P: = 0.05) increased NO release in the presence of 0.1 and 1 mM L-arginine. Furthermore, coincubation of aminoguanidine (NOS inhibitor) with FGF-2 completely abrogated the protective effect of FGF-2 on bcl-2 and bag-1 mRNA levels in PRL-deprived Nb2 cells. In summary, FGF-2 inhibited apoptosis of PRL-deprived Nb2 cells. This antiapoptotic action of FGF-2 appears to be mediated by stimulation of eNOS expression, increased levels of cellular NO, and stimulation of expression of the antiapoptotic genes bcl-2 and bag-1.
Insights
Fibroblast growth factor-2 (FGF-2) prevents apoptosis in prolactin-deprived Nb2 lymphoma cells. FGF-2 increases nitric oxide (NO) production and upregulates antiapoptotic genes bcl-2 and bag-1, promoting cell survival.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Rat Nb2 T lymphoma cells express fibroblast growth factor-2 (FGF-2) and its receptor, suggesting autocrine/paracrine roles.
- Nb2 cells express endothelial nitric oxide synthase (eNOS) and produce nitric oxide (NO), inhibiting apoptosis via a bcl-2-mediated pathway.
- Previous studies indicated NO inhibits apoptosis in prolactin (PRL)-deprived cells independently of PRL.
Purpose of the Study:
- To investigate the effects of PRL and FGF-2 on Nb2 cell survival and NO production.
- To elucidate the molecular mechanisms underlying FGF-2's antiapoptotic effects in PRL-deprived Nb2 cells.
Main Methods:
- Quantification of nonapoptotic cells using flow cytometry.
- Measurement of bcl-2 and bag-1 mRNA levels via quantitative real-time PCR.
- Analysis of eNOS mRNA and protein expression, and NO production.
- Assessment of FGF-2's effects in the presence of a nitric oxide synthase (NOS) inhibitor.
Main Results:
- FGF-2 significantly inhibited apoptosis in PRL-deprived Nb2 cells, maintaining high cell survival (>85%).
- FGF-2 markedly increased bcl-2 and bag-1 mRNA levels, with rapid induction observed within 1 hour.
- FGF-2 upregulated eNOS mRNA and protein expression, leading to increased NO production, which was essential for the observed antiapoptotic effects.
Conclusions:
- FGF-2 exerts a potent antiapoptotic effect on PRL-deprived Nb2 cells.
- This effect is mediated by FGF-2-induced stimulation of eNOS expression, increased NO generation, and subsequent upregulation of antiapoptotic genes bcl-2 and bag-1.
- FGF-2 represents a potential therapeutic target for modulating lymphoma cell survival.
More Related Videos
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
07:20A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery
Published on: February 28, 2020
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Mitogens and the Cell Cycle
The Intrinsic Apoptotic Pathway
Regulation of Angiogenesis and Blood Supply
Introduction to Fibroblasts